Pyrophosphate dysregulation and impaired FGF23/FGFR signaling contributes to impaired matrix mineralization in bone marrow stromal cultures from sickle cell disease mice
Biochemical and Biophysical Research Communications · 2026
DOI: 10.1016/j.bbrc.2025.153152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Liping Xiao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology and Metabolism, UConn Health, School of Medicine, Farmington, CT, 06030, USA. Electronic address: x…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Mesenchymal Stem Cells, Anemia, Sickle Cell, Diphosphates. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Sickle cell disease (SCD) is characterized by osteopenia and impaired bone mineralization, but the underlying mechanisms remain unclear. Fibroblast growth factor 23 (FGF23), elevated in SCD, regulates phosphate metabolism through FGFRs/klotho and contributes to bone loss. Although FGF23's systemic effects are known, its local actions in SCD bone remain poorly defined. Using bone marrow stromal cells (BMSCs) derived from SCD mice, we previously reported that enhanced local FGF23/FGFR1 signaling and increased osteopontin impair osteoblast mineralization, which is rescued by an FGF23-neutralizing antibody (FGF23Ab). Here, we further investigated downstream signaling and pyrophosphate/phosphate (PPi/Pi)-regulatory mechanisms contributing to mineralization defects. FGF23Ab reduced phospho-FGFR1, restored phospho-FGFR2 and phospho-AKT, and decreased pSTAT3 activation. SCD-BMSCs exhibited increased matrix inhibitors, matrix Gla protein (MGP) and matrix extracellular phosphoglycoprotein (MEPE), and reduced mineralization promoters PHEX and DMP1, which were partially normalized by FGF23Ab. FGF23Ab also corrected elevated PPi-generating enzymes ENPP1 and ANK and restored tissue-nonspecific alkaline phosphatase (TNAP). In contrast, the phosphate importer PiT2 was significantly reduced in SCD BMSCs and was further suppressed with FGF23Ab. These findings indicate that excessive local FGF23 signaling disrupts mineralization by upregulating matrix inhibitors and altering PPi/Pi-regulatory pathways. FGF23 neutralization partially restores mineralization capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Endocrinology and Metabolism, UConn Health, School of Medicine, Farmington, CT, 06030, USA. Electronic address: xiao@uchc.edu.
- Department of Medicine, Division of Endocrinology and Metabolism, UConn Health, School of Medicine, Farmington, CT, 06030, USA. Electronic address: hurley@uchc.edu.
Förderung
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Xiao, L., & Hurley, M. M. (2026). Pyrophosphate dysregulation and impaired FGF23/FGFR signaling contributes to impaired matrix mineralization in bone marrow stromal cultures from sickle cell disease mice. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.153152
Vancouver
Xiao L, Hurley MM. Pyrophosphate dysregulation and impaired FGF23/FGFR signaling contributes to impaired matrix mineralization in bone marrow stromal cultures from sickle cell disease mice. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2025.153152
BibTeX
@article{Xiao2026,
author = {Xiao, Liping and Hurley, Marja M},
title = {Pyrophosphate dysregulation and impaired FGF23/FGFR signaling contributes to impaired matrix mineralization in bone marrow stromal cultures from sickle cell disease mice},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
doi = {10.1016/j.bbrc.2025.153152}
}
EUVIMED